Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02240550
Other study ID # P0133
Secondary ID
Status Completed
Phase N/A
First received September 8, 2014
Last updated January 15, 2016
Start date September 2014
Est. completion date December 2014

Study information

Verified date January 2016
Source Insightra Medical, Inc.
Contact n/a
Is FDA regulated No
Health authority India: Ministry of Health
Study type Interventional

Clinical Trial Summary

This investigation will be a double-armed, randomized (Blinded patients and Blinded examiner) prospective study designed to collect perioperative and postoperative data to compare the QOL of ProFlor vs. Lichtenstein inguinal hernia repair.


Description:

The primary objectives of this study will be to evaluate the immediate and short-term amount of post-operative pain, the quality of life (QOL), as well as return to normal activities (work) for the two procedures. Carolinas Comfort Scale (CCS) and Visual Analogue Score (VAS) assessments will be held at regular intervals to evaluate these objectives.

The secondary objective of the study is to identify any short-term study related complications/adverse events.

The follow up will be immediately post-operative, post-operative day 1, and 1, 2,and 4 weeks. The first and 4th week's visits are mandatory office visits (if possible). If not available for office visit, a CCS assessment will be mailed or will be conducted via phone.

Up to 50 patients may be enrolled for this study (25 per arm). A report may be generated for presentation at an international meeting such as the AHS, EHS, or APHS if decided by the lead investigator.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date December 2014
Est. primary completion date November 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Scheduled to undergo routine inguinal hernia repair

- Male and Female patients between 18 and 65 years old

- Competent to give consent

- Clinically relevant inguinal hernia (classification: EHS P L/M 1/2/3)

- Defect size at operation is between 5mm and 35mm

- Diagnosed with unilateral, direct, indirect or mixed inguinal hernia

- Primary hernia at the operative site

Exclusion Criteria:

- Signs of obvious local or systemic infection

- Any previous surgery on the hernia operative site

- Hernia is not in the inguinal area

- Hernia is not identified as indirect or direct

- Femoral hernias

- Known collagen disorder

- Presenting with unstable angina or NYHA class of IV

- Known Pregnancy or Nursing women

- Active drug user

- Recurrence of a repair by any method

- Patients with giant inguinoscrotal hernia or abdominal wall defect >35 mm in diameter - e.g. large direct or combined inguinal hernia type Nyhus IIIb / EHS P L/M 1/2/3

- Immunosuppression, prednisone>15 mg/day, active chemotherapy

- End stage renal disease

- Abdominal ascites

- Skin infection in area of surgical field

- BMI >35

- Peritoneum cannot be closed

- Patient has a clinically relevant co-morbidity (antithrombic prophylaxis due to cardiovascular pathologies, diabetes requiring insulin therapy or immunodeficiency syndrome of any type)

- Neutropenia with absolute neutrophil count (ANC)<500 cells/mm3

- Significant of life-threatening condition (e.g., endocarditis) that would confound or interfere with the procedure

- Patients that require anticoagulant monitoring with an activated partial thromboplastin time (aPTT)

- Patients unwilling to forego blood and/or blood product donation for at least 3 months from initiation of first study device

- Treatment with investigational medicinal product within 30 days before enrollment and for the duration of the study

- Investigational device present, or removed within 30 days before enrollment, or presence of device-related infection

- Patients who the investigator considers unlikely to adhere to the protocol or complete the clinical study

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
ProFlor Hernia Repair System
The 3-D hernia mesh will be used in the repair of your inguinal hernia.
Lichtenstein hernia repair
The standard Lichtenstein hernia repair with flat mesh will be used in the treatment of your inguinal hernia.

Locations

Country Name City State
India Healing Hands Clinic Pune

Sponsors (1)

Lead Sponsor Collaborator
Insightra Medical, Inc.

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluate the immediate and short-term amount of pain. We will evaluate the immediate and short-term amount of pain using the VAS and Carolinas Comfort Scale (CCS) assessments held at regular intervals. 1 month No
Primary Compare the time required for return to normal activities (work). We will capture the time required to return to normal activities as indicated by the patient. 1 month No
Secondary Identify any short-term related complication/adverse events associated with the procedures. 1 month Yes
See also
  Status Clinical Trial Phase
Completed NCT03023462 - Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair N/A
Completed NCT04272320 - The Efficacy of Transversalis Fascia Plane Block in Pediatric Inguinal Hernia Repair N/A
Recruiting NCT03904888 - Conventional Versus Robot Assisted Laparoscopic Inguinal Hernia Repair N/A
Recruiting NCT03856710 - Self Fixating Versus Stapled Mesh for Laparoscopic Inguinal Hernia Repair N/A
Completed NCT01943760 - Tamadol Wound Infiltration in Children Under Inguinal Hernioplasty Phase 4
Completed NCT01679353 - Comparison of Analgesic Effect of Magnesium Added to Ropivacaine and Ropivacaine Alone in Caudal Analgesia on Postoperative Pain Control in Pediatric Patients Undergoing Inguinal Hernia Repair N/A
Recruiting NCT01450345 - Efficacy of Pre-operative Oral Pregabalin in Ambulatory Inguinal Hernia Repair for Post Operative Pain Phase 3
Active, not recruiting NCT00968773 - Rebound Hernia Repair Device Mesh Trial Phase 4
Completed NCT01000116 - Fibrin Glue Versus Tacked Fixation in Groin Hernia Repair (TAPP) N/A
Completed NCT01117337 - Comparing Non-fixation of Mesh to Mesh Fixation in Laparoscopic Inguinal Hernia Repair Phase 4
Terminated NCT00226161 - Chronic Pain After Inguinal Herniorrhaphy N/A
Completed NCT05837013 - Open and Laparoscopic Total Extraperitoneal Repair Under Spinal Anesthesia Versus General Anesthesia N/A
Recruiting NCT05058378 - Correlation Between Spinal Anesthesia and Perfusion Index
Completed NCT01637818 - Long-term Follow-up of Lichtenstein's Operation Versus Mesh Plug Repair N/A
Recruiting NCT05879770 - Is the Use of Prolene as Sufficient as the Use of Wire in Shouldice Surgery to Keep the Recurrence Rate Low After One Year?
Completed NCT05159232 - Length of Hospital Stay in Laparoscopic Transabdominal Preperitoneal Vs. Open Mesh Repair in Inguinal Hernia: A Randomised Controlled Trial N/A
Completed NCT05107986 - Laparoscopy in Complicated Groin Hernia
Active, not recruiting NCT04328597 - Portuguese Inguinal Hernia Cohort (PINE) Study
Completed NCT04033055 - Antalgic Efficacy of CycloMeshâ„¢ Soaked in Ropivacaine Hydrochloride in Uncomplicated Inguinal Hernia. N/A
Completed NCT03590145 - Reliability of the Doha Agreement Classification of Groin Pain